Researchers test potential of artificial blood vessels

04/25/2013 | HealthDay News

Artificial blood vessels made using a biodegradable mesh tube as a scaffold for aorta cells have shown positive results in an animal study and a clinical trial has begun, according to findings presented online through the American Heart Association. The process for the new blood vessel to develop and the mesh structure to dissolve takes two months. Tests on primates showed the synthetic blood vessels can endure frequent needle sticks. A clinical trial in Europe is underway, and a study in the U.S. has been granted FDA authorization.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR